Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases
- PMID: 21978977
Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases
Abstract
Chemokines and chemokine receptors have been implicated in inflammatory cell recruitment and angiogenesis underlying the pathogenesis of rheumatoid arthritis (RA) and other inflammatory rheumatic diseases. Numerous CXC, CC, C and CX3C chemokines and their receptors have been detected in the arthritic synovium and numerous strategies, including biologics, peptide and other small molecule inhibitors of chemokines and their receptors have given promising results in preclinical studies performed in animal models of arthritis. However, most recent human RA trials using antibodies and synthetic compounds have failed. Reasons for negative results of these RA trials include overlapping actions of multiple chemokines, dose-dependency, both antagonistic and agonistic effects of chemokines, chemokine degradation by proteases, as well as effects of anti-inflammatory, regulatory cells. Recent studies have suggested that CCR1 may still be a good target and previous trials may have failed because of the need of sustained CCR1 occupancy throughout the treatment. Therefore, modulation of receptor occupancy may be a feasible option to increase the efficacy of chemokine receptor targeting.
Similar articles
-
Successes and failures of chemokine-pathway targeting in rheumatoid arthritis.Nat Rev Rheumatol. 2016 Jan;12(1):5-13. doi: 10.1038/nrrheum.2015.157. Epub 2015 Nov 26. Nat Rev Rheumatol. 2016. PMID: 26607389 Review.
-
Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.Expert Opin Emerg Drugs. 2005 May;10(2):299-310. doi: 10.1517/14728214.10.2.299. Expert Opin Emerg Drugs. 2005. PMID: 15934868 Review.
-
Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.Cell Mol Immunol. 2004 Oct;1(5):336-42. Cell Mol Immunol. 2004. PMID: 16285892 Review.
-
The role of chemokines in rheumatoid arthritis and osteoarthritis.Scand J Rheumatol. 2005 Nov-Dec;34(6):415-25. doi: 10.1080/03009740500439159. Scand J Rheumatol. 2005. PMID: 16393761 Review.
-
CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.J Bone Miner Res. 2004 Dec;19(12):2065-77. doi: 10.1359/JBMR.040910. Epub 2004 Sep 20. J Bone Miner Res. 2004. PMID: 15537451
Cited by
-
G protein signaling modulator-3: a leukocyte regulator of inflammation in health and disease.Am J Clin Exp Immunol. 2014 Aug 15;3(2):97-106. eCollection 2014. Am J Clin Exp Immunol. 2014. PMID: 25143870 Free PMC article. Review.
-
Cellular and Molecular Aspects of Bone Remodeling.Front Oral Biol. 2016;18:9-16. doi: 10.1159/000351895. Epub 2015 Nov 24. Front Oral Biol. 2016. PMID: 26599113 Free PMC article. Review.
-
Genetics of rheumatoid arthritis - a comprehensive review.Clin Rev Allergy Immunol. 2013 Oct;45(2):170-9. doi: 10.1007/s12016-012-8346-7. Clin Rev Allergy Immunol. 2013. PMID: 23288628 Free PMC article. Review.
-
Recombinant human interleukin receptor antagonist influences serum chemokines in patients with rheumatoid arthritis.Cent Eur J Immunol. 2014;39(2):170-3. doi: 10.5114/ceji.2014.43717. Epub 2014 Jun 27. Cent Eur J Immunol. 2014. PMID: 26155119 Free PMC article.
-
Comprehensive Bioinformatics Analysis Reveals Hub Genes and Inflammation State of Rheumatoid Arthritis.Biomed Res Int. 2020 Aug 3;2020:6943103. doi: 10.1155/2020/6943103. eCollection 2020. Biomed Res Int. 2020. PMID: 32802866 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous